Progressive supranuclear palsy (PSP)
Would you like to receive a message when new research about Progressive Supranuclear Palsy (PSP) is available? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there is new research on Progressive Supranuclear Palsy (PSP). View what Premium costs.
Publications and studies (1196)
- Neurofilament Levels Are Reflecting the Loss of Presynaptic Dopamine Receptors in Movement Disorders. (2021/12/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. "Parkinson's disease" on the way to progressive supranuclear palsy: a review on PSP-parkinsonism. (2021/12/01) ♡
- Distinct phosphorylation profiles of tau in brains of patients with different tauopathies. (2021/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Neuroprotective treatment of tauopathies]. (2021/12/01) ♡
- Parkinson's disease and parkinsonism: Clinicopathological discrepancies on diagnosis in three patients. (2021/12/01) ♡
- Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study. (2021/12/01) ♡
- Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach. (2021/11/30) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Umbilical cord blood stem cells transplantation in a patient with severe progressive supranuclear palsy: a case report. (2021/11/29) ♡
- (18)F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies. (2021/11/29) ♡
- Segmental Alterations of the Corpus Callosum in Progressive Supranuclear Palsy: A Multiparametric Magnetic Resonance Imaging Study. (2021/11/19) ♡
- Retina tissue validation of optical coherence tomography determined outer nuclear layer loss in FTLD-tau. (2021/11/18) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. In vitro characterization of [(3)H]VAT in cells, animal and human brain tissues for vesicular acetylcholine transporter. (2021/11/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms. (2021/11/15) ♡
- Accuracy of Magnetic Resonance Parkinsonism Index in Differentiating Progressive Supranuclear Palsy from Parkinson's Disease among South Indian Population: A Retrospective Case Control Study. (2021/11/13) ♡
- Rare CYLD Variants in Chinese Patients With Amyotrophic Lateral Sclerosis. (2021/11/12) ♡
- The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability-A Pilot Study. (2021/11/08) ♡
- Eye-of-the-Tiger Sign with an Unexpected Pathological Diagnosis. (2021/11/07) ♡
- TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy. (2021/11/05) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Concomitant Alzheimer's and Lewy-Related Pathology Extending the Spectrum of Underlying Pathologies of Corticobasal Syndrome. (2021/11/03) ♡
- Human wildtype tau expression in cholinergic pedunculopontine tegmental neurons is sufficient to produce PSP-like behavioural deficits and neuropathology. (2021/11/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Administration of 4 mA tDCS to a person with progressive supranuclear palsy leads to improved walking speed. (2021/11/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Development of a cognitive composite for measuring change in progressive supranuclear palsy. (2021/11/01) ♡
- Central Ocular Motor Disorders: Clinical and Topographic Anatomical Diagnosis, Syndromes and Underlying Diseases. (2021/11/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. An Unusual Presentation of Progressive Supranuclear Palsy. (2021/11/01) ♡
- Semantic Fluency Predicts Gait Velocity in PSP. (2021/11/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Neuropathology of SCA34 showing widespread oligodendroglial pathology with vacuolar white matter degeneration: a case study. (2021/10/24) ♡
- Intracortical diffusion tensor imaging signature of microstructural changes in frontotemporal lobar degeneration. (2021/10/22) ♡
- Deep learning reveals disease-specific signatures of white matter pathology in tauopathies. (2021/10/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Human Tau Isoforms and Proteolysis for Production of Toxic Tau Fragments in Neurodegeneration. (2021/10/21) ♡
- Tackling the Biological Meaning of the Human Olfactory Bulb Dyshomeostatic Proteome across Neurological Disorders: An Integrative Bioinformatic Approach. (2021/10/20) ♡
- Longitudinal Assessment of Tau-Associated Pathology by (18)F-THK5351 PET Imaging: A Histological, Biochemical, and Behavioral Study. (2021/10/12) ♡
- Safety and Effectiveness of Cell Therapy in Neurodegenerative Diseases: Take-Home Messages From a Pilot Feasibility Phase I Study of Progressive Supranuclear Palsy. (2021/10/12) ♡
- First delirium episode in Parkinson's disease and parkinsonism: incidence, predictors, and outcomes. (2021/10/11) ♡
- Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes. (2021/10/11) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Neuropathology of progressive supranuclear palsy after treatment with tilavonemab. (2021/10/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Neuropathology of progressive supranuclear palsy after treatment with tilavonemab - Author's reply. (2021/10/01) ♡
- Structure-based classification of tauopathies. (2021/10/01) ♡
- FTD-PSP is an Unusual Clinical Phenotype in A Frontotemporal Dementia Patient with A Novel Progranulin Mutation. (2021/10/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP-RS and vPSP. (2021/10/01) ♡
- Ocular Motor Abnormalities in Anti-IgLON5 Disease. (2021/09/30) ♡
- Transcriptome analyses reveal tau isoform-driven changes in transposable element and gene expression. (2021/09/29) ♡
- Severity of Downgaze Palsy in the Context of Disease Duration Could Estimate Survival Duration in Patients With Progressive Supranuclear Palsy. (2021/09/28) ♡
- Co-Occurrence of Apathy and Impulsivity in Progressive Supranuclear Palsy. (2021/09/16) ♡
- Hospital Admissions for Neurodegenerative Diseases during the First Wave of the COVID-19 Pandemic: A Nationwide Cross-Sectional Study from Germany. (2021/09/15) ♡
- Neuronal VPS35 deletion induces spinal cord motor neuron degeneration and early post-natal lethality. (2021/09/10) ♡
- Social Behavior Observer Checklist: Patterns of Spontaneous Behaviors Differentiate Patients With Neurodegenerative Disease From Healthy Older Adults. (2021/09/07) ♡
- Strategy Adherence: A Specific and Rapidly Progressive Deficit in Progressive Supranuclear Palsy. (2021/09/04) ♡
- Brain changes underlying progression of speech motor programming impairment. (2021/09/02) ♡
- Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants. (2021/09/02) ♡
- Neuropsychological assessment could distinguish among different clinical phenotypes of progressive supranuclear palsy: A Machine Learning approach. (2021/09/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.